放疗后中性粒细胞与淋巴细胞比值升高预示胰腺癌不良预后并与脾脏放疗剂量相关
该回顾性研究纳入101例接受诱导化疗后放疗的临界可切除或局部晚期胰腺癌患者,探讨放疗后中性粒细胞与淋巴细胞比值变化(ΔNLR)对手术切除和总生存的预测价值,以及脾脏放疗剂量对ΔNLR的影响。结果显示ΔNLR是总生存的独立不良预后因素,且ΔNLR≥2.5与更高的脾脏剂量参数相关。
要点
- 放疗后ΔNLR升高显著预测更差的总生存和更低的手术切除率。
- ΔNLR最佳截断值为2.5,ΔNLR<2.5者总生存显著更长。
- ΔNLR≥2.5患者脾脏剂量参数均显著更高,提示脾脏可能为重要危及器官。
核心结论
- 在接受诱导化疗的临界可切除或局部晚期胰腺癌患者中,放疗后ΔNLR升高显著预测更差的总生存和更低的手术切除率。
- ΔNLR与更高的脾脏放疗剂量相关,提示脾脏可能是重要的危及器官。
研究设计与样本
- 回顾性纳入101例活检证实的临界可切除或局部晚期胰腺癌患者,均接受诱导化疗后放疗。
- 勾画脾脏并计算脾脏剂量体积直方图参数,记录放疗前后两周内的全血细胞计数,Δ值由放疗前值减放疗后值计算。
- 采用Cox回归分析放疗前后血细胞计数与总生存的关系,生成ROC曲线确定最佳截断点,绘制Kaplan-Meier生存曲线。
主要发现
- 单因素Cox回归分析中,唯一与总生存显著相关的血细胞计数指标为ΔNLR(HR 1.06,CI 1.03-1.09,p < 0.001)。
- 多因素分析中,ΔNLR、年龄和完成切除均显著预测更差的总生存(p < 0.05)。
- ΔNLR显著预测手术切除的实现(p = 0.04),ΔNLR最佳截断点为2.5。
- ΔNLR < 2.5的患者总生存显著更长(log rank p = 0.046)。
- ΔNLR ≥ 2.5的患者脾脏放疗剂量参数均显著更高。
关键数值与推荐
- ΔNLR最佳截断点为2.5。
- 预测ΔNLR ≥ 2.5的最佳脾脏放疗截断点为脾脏Dmean 308 cGy和V5 10.3%。
临床怎么用
- 放疗前后可监测ΔNLR,ΔNLR≥2.5提示预后较差且手术切除可能性降低。
- 放疗计划中可将脾脏作为危及器官加以考虑,限制脾脏Dmean和V5可能有助于降低ΔNLR升高的风险。
局限性
- 本研究为回顾性研究,样本量101例,可能存在选择偏倚。
- 放疗前后全血细胞计数仅记录两周内的数据,ΔNLR的最佳截断点2.5及脾脏剂量截断点需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Neutrophil-to-lymphocyte ratio has been correlated with clinical outcomes in many cancers. We investigated whether the delta-NLR (ΔNLR) following radiation therapy (RT) could predict achieving surgical resection and the overall survival (OS) of patients with borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC), and whether the splenic radiation dose impacted ΔNLR. METHODS/MATERIALS: 101 patients with biopsy-proven BRPC or LAPC who received induction chemotherapy followed by RT were retrospectively enrolled. Following contouring of spleens, dose-volume histograms (DVHs) for splenic dosimetric parameters were calculated. Pre- and post-RT complete blood counts (CBC) within two weeks were recorded. Delta (Δ) values were calculated by subtracting the post-RT value from the pre-RT value. Cox regression survival analysis for pre and postradiation CBC values and OS was performed. Receiver operating curves (ROC) were generated and optimal cutoff points for highest sensitivity and specificity were identified. Kaplan-Meier curves for OS were generated. RESULTS: On univariate Cox regression analysis, the only significant CBC value associated with OS was ΔNLR (HR 1.06, CI 1.03-1.09, p < 0.001). On multivariate analysis, ΔNLR, age, and completed resection all significantly predicted for worse OS (p < 0.05). ΔNLR significantly predicted achieving surgical resection (p = 0.04) and the optimal cutoff point for ΔNLR was 2.5. Patients with ΔNLR < 2.5 had significantly longer OS (log rank p = 0.046). Spleen radiation dose parameters were all significantly higher in patients with a ΔNLR ≥ 2.5. Optimal radiation cutoff points to predict a ΔNLR ≥ 2.5 were splenic Dmean of 308 cGy and V5 of 10.3%. CONCLUSIONS: Among patients with BRPC or LAPC who have received induction chemotherapy, elevated ΔNLR after RT significantly predicts worse OS and decreased odds of achieving resection. Furthermore, ΔNLR is correlated with higher splenic doses, suggesting the spleen may be an important organ at risk.
引用
- Wolfe AR, Siedow M, Nalin A, et al. Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer. Radiother Oncol. 2021. PMID: 33667588. doi:10.1016/j.radonc.2021.02.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。